Molbio Diagnostics, a leading point-of-care molecular diagnostics company, is set to launch its initial public offering (IPO) on August 10, 2026, with a price band of Rs 768 to Rs 807 per share. The IPO, which will remain open for subscription until August 12, 2026, is expected to raise approximately Rs 939.70 crore.
The issue comprises a fresh issue of shares worth Rs 200 crore and an offer for sale (OFS) component amounting to Rs 739.70 crore. Under the OFS route, existing shareholders of the company will sell part of their holdings.
